(-)-demecolcine decreases expression ISO RGD:730989 6480464 Demecolcine results in decreased expression of SLC4A7 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:730989 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC4A7 mRNA CTD PMID:22079256 1,1-dichloroethene increases expression ISO RGD:736860 6480464 vinylidene chloride results in increased expression of SLC4A7 mRNA CTD PMID:26682919 1,2-dichloroethane increases expression ISO RGD:736860 6480464 ethylene dichloride results in increased expression of SLC4A7 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:736860 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC4A7 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of SLC4A7 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:730989 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SLC4A7 mRNA CTD PMID:20660070 17beta-estradiol increases expression ISO RGD:730989 6480464 Estradiol results in increased expression of SLC4A7 mRNA CTD PMID:31614463 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:730989 6480464 Dihydrotestosterone results in increased expression of SLC4A7 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:730989 6480464 Tetrachlorodibenzodioxin affects the expression of SLC4A7 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC4A7 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC4A7 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:730989 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC4A7 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:730989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC4A7 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC4A7 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:736860 6480464 Fenretinide results in increased expression of SLC4A7 mRNA CTD PMID:28973697 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC4A7 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:730989 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC4A7 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC4A7 mRNA CTD PMID:32699268 aflatoxin B1 increases methylation ISO RGD:730989 6480464 Aflatoxin B1 results in increased methylation of SLC4A7 gene CTD PMID:27153756 all-trans-retinoic acid affects expression ISO RGD:730989 6480464 Tretinoin affects the expression of SLC4A7 mRNA CTD PMID:15498508 alpha-pinene multiple interactions ISO RGD:730989 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC4A7 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of SLC4A7 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC4A7 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:730989 6480464 aristolochic acid I results in decreased expression of SLC4A7 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:730989 6480464 arsenite inhibits the reaction [G3BP1 protein binds to SLC4A7 mRNA] CTD PMID:32406909 benzo[a]pyrene increases expression ISO RGD:730989 6480464 Benzo(a)pyrene results in increased expression of SLC4A7 mRNA CTD PMID:21871943 benzo[a]pyrene affects methylation ISO RGD:730989 6480464 Benzo(a)pyrene affects the methylation of SLC4A7 promoter CTD PMID:27901495 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC4A7 mRNA CTD PMID:25181051 , PMID:33296240 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC4A7 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:730989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC4A7 mRNA CTD PMID:28628672 bisphenol F multiple interactions ISO RGD:730989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC4A7 mRNA CTD PMID:28628672 caffeine affects phosphorylation ISO RGD:730989 6480464 Caffeine affects the phosphorylation of SLC4A7 protein CTD PMID:35688186 calcitriol increases expression ISO RGD:730989 6480464 Calcitriol results in increased expression of SLC4A7 mRNA CTD PMID:16002434 , PMID:26485663 carbamazepine affects expression ISO RGD:730989 6480464 Carbamazepine affects the expression of SLC4A7 mRNA CTD PMID:25979313 chromium(6+) decreases expression ISO RGD:730989 6480464 chromium hexavalent ion results in decreased expression of SLC4A7 mRNA CTD PMID:30690063 ciglitazone multiple interactions ISO RGD:730989 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of SLC4A7 mRNA CTD PMID:16197558 cisplatin multiple interactions ISO RGD:730989 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of SLC4A7 mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:730989 6480464 Cisplatin results in decreased expression of SLC4A7 mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:730989 6480464 cobaltous chloride results in decreased expression of SLC4A7 mRNA CTD PMID:19376846 copper(II) sulfate increases expression ISO RGD:730989 6480464 Copper Sulfate results in increased expression of SLC4A7 mRNA CTD PMID:19549813 coumarin affects phosphorylation ISO RGD:730989 6480464 coumarin affects the phosphorylation of SLC4A7 protein CTD PMID:35688186 crocidolite asbestos increases expression ISO RGD:730989 6480464 Asbestos, Crocidolite results in increased expression of SLC4A7 mRNA CTD PMID:18687144 cyclosporin A decreases expression ISO RGD:730989 6480464 Cyclosporine results in decreased expression of SLC4A7 mRNA CTD PMID:22147139 cyclosporin A increases expression ISO RGD:730989 6480464 Cyclosporine results in increased expression of SLC4A7 mRNA CTD PMID:20106945 , PMID:25562108 deoxynivalenol increases expression ISO RGD:730989 6480464 deoxynivalenol results in increased expression of SLC4A7 mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO RGD:730989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC4A7 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC4A7 mRNA CTD PMID:28628672 dextran sulfate multiple interactions ISO RGD:736860 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC4A7 mRNA CTD PMID:29950665 dorsomorphin multiple interactions ISO RGD:730989 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC4A7 mRNA CTD PMID:27188386 elemental selenium decreases expression ISO RGD:730989 6480464 Selenium results in decreased expression of SLC4A7 mRNA CTD PMID:19244175 entinostat decreases expression ISO RGD:730989 6480464 entinostat results in decreased expression of SLC4A7 mRNA CTD PMID:27188386 ethyl methanesulfonate decreases expression ISO RGD:730989 6480464 Ethyl Methanesulfonate results in decreased expression of SLC4A7 mRNA CTD PMID:23649840 fenthion increases expression ISO RGD:736860 6480464 Fenthion results in increased expression of SLC4A7 mRNA CTD PMID:34813904 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLC4A7 mRNA CTD PMID:18035473 folic acid increases expression ISO RGD:736860 6480464 Folic Acid results in increased expression of SLC4A7 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:730989 6480464 Formaldehyde results in decreased expression of SLC4A7 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC4A7 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:730989 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of SLC4A7 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of SLC4A7 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:730989 6480464 Ivermectin results in decreased expression of SLC4A7 protein CTD PMID:32959892 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of SLC4A7 mRNA CTD PMID:22641619 lead(0) multiple interactions ISO RGD:730989 6480464 SLC4A7 affects the abundance of and affects the transport of Lead CTD PMID:17687451 lead(2+) multiple interactions ISO RGD:730989 6480464 SLC4A7 affects the abundance of and affects the transport of Lead CTD PMID:17687451 leflunomide increases expression ISO RGD:730989 6480464 leflunomide results in increased expression of SLC4A7 mRNA CTD PMID:28988120 levetiracetam increases expression EXP 6480464 Levetiracetam results in increased expression of SLC4A7 mRNA CTD PMID:20345932 methyl methanesulfonate decreases expression ISO RGD:730989 6480464 Methyl Methanesulfonate results in decreased expression of SLC4A7 mRNA CTD PMID:23649840 methylmercury chloride multiple interactions ISO RGD:730989 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC4A7 mRNA CTD PMID:27188386 methylmercury chloride increases expression ISO RGD:730989 6480464 methylmercuric chloride results in increased expression of SLC4A7 mRNA CTD PMID:28001369 mirex increases expression EXP 6480464 Mirex results in increased expression of SLC4A7 mRNA CTD PMID:23153324 naphthalene increases expression EXP 6480464 naphthalene analog results in increased expression of SLC4A7 mRNA CTD PMID:24976557 nickel dichloride decreases expression ISO RGD:730989 6480464 nickel chloride results in decreased expression of SLC4A7 mRNA CTD PMID:17312168 ozone multiple interactions ISO RGD:730989 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of SLC4A7 mRNA more ... CTD PMID:32699268 paracetamol increases expression ISO RGD:730989 6480464 Acetaminophen results in increased expression of SLC4A7 mRNA CTD PMID:26497421 , PMID:29067470 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC4A7 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:730989 6480464 Acetaminophen affects the expression of SLC4A7 mRNA CTD PMID:25458485 paracetamol affects expression ISO RGD:736860 6480464 Acetaminophen affects the expression of SLC4A7 mRNA CTD PMID:17562736 perfluorooctanoic acid increases expression ISO RGD:730989 6480464 perfluorooctanoic acid results in increased expression of SLC4A7 protein CTD PMID:26879310 phenobarbital affects expression ISO RGD:736860 6480464 Phenobarbital affects the expression of SLC4A7 mRNA CTD PMID:23091169 pirinixic acid multiple interactions ISO RGD:736860 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC4A7 mRNA CTD PMID:18489776 potassium chromate multiple interactions ISO RGD:730989 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC4A7 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:730989 6480464 potassium chromate(VI) results in decreased expression of SLC4A7 mRNA CTD PMID:22079256 , PMID:22714537 progesterone multiple interactions ISO RGD:730989 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of SLC4A7 mRNA CTD PMID:20660070 quercetin increases expression ISO RGD:730989 6480464 Quercetin results in increased expression of SLC4A7 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:730989 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC4A7 mRNA CTD PMID:27188386 selenium atom decreases expression ISO RGD:730989 6480464 Selenium results in decreased expression of SLC4A7 mRNA CTD PMID:19244175 sodium arsenate decreases expression ISO RGD:736860 6480464 sodium arsenate results in decreased expression of SLC4A7 mRNA CTD PMID:21795629 sodium arsenate increases expression ISO RGD:736860 6480464 sodium arsenate results in increased expression of SLC4A7 mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:736860 6480464 sodium arsenite results in increased expression of SLC4A7 mRNA CTD PMID:36209798 sodium fluoride decreases expression EXP 6480464 Sodium Fluoride results in decreased expression of SLC4A7 mRNA CTD PMID:27257137 sotorasib multiple interactions ISO RGD:730989 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC4A7 mRNA CTD PMID:36139627 succimer multiple interactions ISO RGD:736860 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC4A7 mRNA CTD PMID:21641980 tamibarotene affects expression ISO RGD:730989 6480464 tamibarotene affects the expression of SLC4A7 mRNA CTD PMID:15498508 testosterone increases expression ISO RGD:736860 6480464 Testosterone deficiency results in increased expression of SLC4A7 mRNA CTD PMID:33848595 testosterone enanthate affects expression ISO RGD:730989 6480464 testosterone enanthate affects the expression of SLC4A7 mRNA CTD PMID:17440010 tetrachloromethane increases expression ISO RGD:736860 6480464 Carbon Tetrachloride results in increased expression of SLC4A7 mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:736860 6480464 Thapsigargin results in increased expression of SLC4A7 protein CTD PMID:24648495 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC4A7 mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:736860 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC4A7 mRNA CTD PMID:29950665 trametinib multiple interactions ISO RGD:730989 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SLC4A7 mRNA CTD PMID:36139627 tributylstannane increases expression ISO RGD:736860 6480464 tributyltin results in increased expression of SLC4A7 mRNA CTD PMID:31939706 trichostatin A decreases expression ISO RGD:730989 6480464 trichostatin A results in decreased expression of SLC4A7 mRNA CTD PMID:24935251 valproic acid affects expression ISO RGD:730989 6480464 Valproic Acid affects the expression of SLC4A7 mRNA CTD PMID:25979313 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of SLC4A7 mRNA CTD PMID:29427782 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of SLC4A7 mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:730989 6480464 Valproic Acid results in decreased expression of SLC4A7 mRNA CTD PMID:23179753 more ... vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SLC4A7 mRNA CTD PMID:23034163 vincristine decreases expression ISO RGD:730989 6480464 Vincristine results in decreased expression of SLC4A7 mRNA CTD PMID:23649840 vitamin E decreases expression ISO RGD:730989 6480464 Vitamin E results in decreased expression of SLC4A7 mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:730989 6480464 vorinostat results in decreased expression of SLC4A7 mRNA CTD PMID:27188386
